Physician profile
Justin G Pointer
NPI 1659636082
$20,639.87
in general payments reported to CMS, 2019-2025
26 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $41.36 · 2021: $3,232 · 2022: $3,994 · 2023: $11K · 2024: $1,188 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,644 · Travel and Lodging: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $1,644.39 |
| Travel and Lodging | $950.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $7,750.00 | 2023 | Lapidus Instruments |
| Musculoskeletal Transplant Foundation INC. | $5,969.03 | 2022-2024 | |
| Stryker Corporation | $2,803.92 | 2019-2025 | Prophecy, Prostep, Inbone |
| Supreme Orthopedic Systems, LLC | $2,434.86 | 2021-2023 | |
| Cardiovascular Systems INC. | $301.46 | 2019-2021 | |
| Integra Lifesciences Corporation | $253.92 | 2021-2023 | Tenoglide |
| Kerecis Limited | $239.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $121.97 | 2019-2024 | Collagenase Santyl |
| Abbott Laboratories | $107.71 | 2025 | Esprit |
| Orthofix Medical, INC. | $94.28 | 2021-2025 | Truelok |
| Organogenesis INC. | $91.02 | 2022-2024 | Puraply Franchise |
| Ossio INC | $86.60 | 2021-2022 | |
| Treace Medical Concepts, INC. | $48.08 | 2025 | |
| Arteriocyte Medical Systems, INC. | $46.87 | 2021 | |
| Linvatec Corporation | $46.81 | 2025 | Neospan, Hercules Suture Anchor System, Biobrace 23mm |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $45.98 | 2021 | |
| Paragon 28, INC. | $35.61 | 2022 | |
| Bioventus LLC | $26.30 | 2024 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $23.17 | 2025 | Senza |
| Mimedx Group, INC. | $23.02 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $22.32 | 2025 | Exparel, Iovera |
| Arthrosurface Incorporated | $16.59 | 2019 | |
| Curonix LLC | $15.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimmer Biomet Holdings, INC. | $11.96 | 2019 | |
| Kuros Biosciences USA, INC | $11.70 | 2022 | |
| Misonix INC | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Pointer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.